Press release
Pulmonary Arterial Hypertension Market: 2024 Global Type, Application, Trends, Demand Service, Share, Industry Size, Growth, Region, Opportunities and Forecast to 2031 | Arena Pharmaceuticals, Bayer AG, Bristol-Myers Squibb Company
Pulmonary Arterial Hypertension Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://www.datamintelligence.com/download-sample/pulmonary-arterial-hypertension-market?ch
What is the projected growth of the Global Pulmonary Arterial Hypertension market?
The Global Pulmonary Arterial Hypertension Market size was worth USD 7 billion in 2022 and is estimated to reach USD 10.6 billion by 2030, growing at a CAGR of 5.3% during the forecast period 2024-2031.
What is Pulmonary Arterial Hypertension Market?
Pulmonary arterial hypertension (PAH) is a chronic and progressive condition characterized by high blood pressure in the arteries that supply blood to the lungs. It occurs when the pulmonary arteries narrow or become blocked, making it harder for the heart to pump blood through them. This leads to symptoms such as shortness of breath, fatigue, chest pain, and dizziness. PAH can be caused by genetic factors, underlying diseases, or unknown reasons (idiopathic PAH). Treatment options include vasodilators, anticoagulants, oxygen therapy, and, in severe cases, lung transplantation to help manage symptoms and improve quality of life.
Who are the major players in the Pulmonary Arterial Hypertension market?
The prominent players in Pulmonary Arterial Hypertension market research report are: Arena Pharmaceuticals, Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences Inc, GlaxoSmithKline Plc, Actelion Pharmaceuticals, Ltd. (Johnson & Johnson), Merck & Co. Inc, Novartis International AG, Pfizer Inc, United Therapeutics Corporation. The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
In May 2023, ICER announced it would review sotatercept for pulmonary arterial hypertension (PAH), assessing its clinical effectiveness and value. Sotatercept works by preventing abnormal signaling in pulmonary blood vessels, counteracting PAH's underlying mechanism.
In May 2023, Gossamer Bio planned to start a Phase 3 trial for seralutinib (GB002), an investigational inhaled therapy for PAH.
In April 2023, the FDA approved Treprostinil injection, a generic version of Remodulin by Dr. Reddy's, for PAH treatment in multiple vial strengths.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/pulmonary-arterial-hypertension-market
Market Segments
By Drug Class: Prostacyclin and Prostacyclin Analogs, Calcium Channel Blockers, Phosphodiesterase 5 (PDE-5), Endothelin Receptor Antagonists (ERA), and Others
By Route of Administration: Inhalation, Injectable and Oral Administration
By Distribution channel: Hospital Pharmacy, Pharmacy stores, and Others
The Pulmonary Arterial Hypertension industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Pulmonary Arterial Hypertension Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/pulmonary-arterial-hypertension-market
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Arterial Hypertension Market: 2024 Global Type, Application, Trends, Demand Service, Share, Industry Size, Growth, Region, Opportunities and Forecast to 2031 | Arena Pharmaceuticals, Bayer AG, Bristol-Myers Squibb Company here
News-ID: 3886162 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Antioxidants Market Is Booming By Vita Foods 2026: Top Companies - Kaneka Medica …
DataM Intelligence has published a new research report on "Antioxidants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Antioxidants Market Size reached US$ 5.34 billion in 2024…
Global Krill for Pet Food Market Trends & Industry Insights 2025 | Major Compani …
Global Krill for Pet Food Market reached US$ 410.2 million in 2022 and is expected to reach US$ 1,001.2 million by 2031, growing with a CAGR of 11.8% during the forecast period 2024-2031.
The Krill for Pet Food Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple…
Herbal Supplements Market 2025: Global Trends, Opportunities & Vita Foods 2026 - …
DataM Intelligence has published a new research report on "Herbal Supplements Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report (Get…
Future of Animal Parasiticides Market: Sustainable and Effective Parasite Contro …
Global Animal Parasiticides market reached US$ 11.8 billion in 2022 and is expected to reach US$ 19.09 billion by 2031, growing with a CAGR of 6.2% during the forecast period 2024-2031.
The Animal Parasiticides Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
